|Articles|April 1, 2014
- Applied Clinical Trials-04-01-2014
- Volume 23
- Issue 4
Applied Clinical Trials Digital Edition April/May 2014
Sites: Making a Difference in Cancer Trials Accrual Trial Design: Oncology Trial Comparator Drug Reimbursement Also in this issue: Singular Approach to Combination Trials Risk Sharing and Interrupted Drug Development Cardio-Oncology: A New Clinical Discipline
Advertisement
Articles in this issue
over 11 years ago
Oncology Trial Comparator Drug Reimbursement: A Canadian Perspectiveover 11 years ago
Business and People April 2014over 11 years ago
Europe Puts Renewed Emphasis on Patient Communicationover 11 years ago
Making a Difference in Cancer Trials Accrualover 11 years ago
Analyzing 2013 Oncology Trends to Predict 2014 Directionsover 11 years ago
Singular Approaches to Combination Trialsover 11 years ago
Delivery Strength from Midsize CROsover 11 years ago
Pressure Grows for More Inclusive Clinical Trialsover 11 years ago
Coming to Terms with Interrupted Drug Development Programsover 11 years ago
The New Road of Cardio-Oncology in Clinical DevelopmentNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
When AI Learns to Speak Every Language: An eCOA Migration Study
2
Upskilling Community Cancer Centers: A Training Pilot Hints at Promising Ways to Boost Oncology Clinical Research
3
ACT Brief: AI-Enabled COA Migration, Expanding Trial Footprints into Routine Care, and New FDA Approval in Myasthenia Gravis
4
FDA Outlines New Superiority Standard for Future CAR-T Approvals
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
